Clinical Trial Update: A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 bioequivalence study in open-angle glaucoma and ocular hypertension, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Amneal ophthalmic solution (investigational)

Snippet

Sponsor: Amneal Pharmaceuticals, LLC | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 1 | Status: RECRUITING